Ubiquitination and TRAF signaling (original) (raw)

• Ciechanover A, Heller H, Elias S et al. ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation. Proc Natl Acad Sci USA 1980; 77(3):1365–8.
  Article PubMed CAS Google Scholar
• Hershko A, Ciechanover A, Rose IA. Resolution of the ATP-dependent proteolytic system from reticulocytes: A component that interacts with ATP. Proc Natl Acad Sci USA 1979; 76(7):3107–10.
  Article PubMed CAS Google Scholar
• Pickart CM. Back to the future with ubiquitin. Cell 2004; 116(sn2):181–90.
  Article PubMed CAS Google Scholar
• Finley D. Ubiquitin chained and crosslinked. Nat Cell Biol 2002; 4(5):E121–3.
  Article PubMed CAS Google Scholar
• Petroski MD, Deshaies RJ. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 2005; 6(1):9–20.
  Article PubMed CAS Google Scholar
• Jin J, Cardozo T, Lovering RC et al. Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev 2004; 18(21):2573–80.
  Article PubMed CAS Google Scholar
• Cardozo T, Pagano M. The SCF ubiquitin ligase: Insights into a molecular machine. Nat Rev Mol Cell Biol 2004; 5(9):739–51.
  Article PubMed CAS Google Scholar
• Weissman AM. Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol 2001; 2(3):169–78.
  Article PubMed CAS Google Scholar
• Huibregtse JM, Scheffner M, Beaudenon S et al. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc Natl Acad Sci USA 1995; 92(7):2563–7.
  Article PubMed CAS Google Scholar
• King RW, Peters JM, Tugendreich S et al. A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell 1995; 81(2):279–88.
  Article PubMed CAS Google Scholar
• Sudakin V, Ganoth D, Dahan A et al. The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol Biol Cell 1995; 6(2):185–97.
  PubMed CAS Google Scholar
• Winston JT, Strack P, Beer-Romero P et al. The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev 1999; 13(3):270–83.
  PubMed CAS Google Scholar
• Yaron A, Hatzubai A, Davis M et al. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature 1998; 396(6711):590–4.
  Article PubMed CAS Google Scholar
• Spencer E, Jiang J, Chen ZJ. Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP. Genes Dev 1999; 13(3):284–94.
  PubMed CAS Google Scholar
• Carrano AC, Eytan E, Hershko A et al. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999; 1(4):193–9.
  Article PubMed CAS Google Scholar
• Scheffner M., Nuber U, Huibregtse JM. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 1995; 373(6509):81–3.
  Article PubMed CAS Google Scholar
• Huibregtse JM, Scheffner M, Howley PM. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol 1993; 13(2):775–84.
  PubMed CAS Google Scholar
• Huibregtse JM, Scheffner M, Howley PM. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 1991; 10(13):4129–35.
  PubMed CAS Google Scholar
• Scheffner M, Werness BA, Huibregtse JM et al. The E6 oncoprotein encoded by human ipapillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63(6):1129–36.
  Article PubMed CAS Google Scholar
• Rotin D,, Staub O, Haguenauer-Tsapis R. Ubiquitination and endocytosis of plasma membrane proteins: Role of Nedd4/Rsp5p family of ubiquitin-protein ligases. J Membr Biol 2000; 176(1):1–17.
  Article PubMed CAS Google Scholar
• Amerik AY, Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta 2004; 1695(1–3):189–207.
  PubMed CAS Google Scholar
• Silverman N, Maniatis T. NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev 2001; 15(18):2321–42.
  Article PubMed CAS Google Scholar
• Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002; 2(10):725–34.
  Article PubMed CAS Google Scholar
• Hayden MS, Ghosh S., Signaling to NF-kappaB. Genes Dev 2004; 18(18):2195–224.
  Article PubMed CAS Google Scholar
• Pomerantz JL, Baltimore D. Two pathways to NF-kappaB. Mol Cell 2002; 10(4):693–5.
  Article PubMed CAS Google Scholar
• Lin L, DeMartino GN, Greene WC. Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell 1998; 92(6):819–28.
  Article PubMed CAS Google Scholar
• Palombella VJ, Rando OJ, Goldberg AL et al. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 1994; 78(5):773–85.
  Article PubMed CAS Google Scholar
• Waterfield MR, Zhang M, Norman LP et al. NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase. Mol Cell 2003; 11(3):685–94.
  Article PubMed CAS Google Scholar
• Deng L, Chen Z. Role of ubiquitin in NF-kB signaling. In: Beyaert R, ed. Nuclear Factor kB. Regulation and Role in Disease. Dordrecht/Boston/London: Kluwer, 2003;139–160.
  Google Scholar
• Zheng N, Schulman BA, Song L et al. Structure of the Cul1-Rbx1-F boxSkp2 SCF ubiquitin ligase complex. Nature 2002; 416(6882):703–9.
  Article PubMed CAS Google Scholar
• Wu G, Xu G, Schulman BA et al. Structure of a beta-TrCP1-Skp1-beta-catenin complex: Destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase. Mol Cell 2003; 11(6):1445–56.
  Article PubMed CAS Google Scholar
• Chung JY, Park YC, Ye H et al. All TRAFs are not created equal: Common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci 2002; 115(Pt 4):679–88.
  PubMed CAS Google Scholar
• Bradley JR, Pober JS. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 2001; 20(44):6482–91.
  Article PubMed CAS Google Scholar
• Rothe M, Wong SC, Henzel WJ et al. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 1994; 78(4):681–92.
  Article PubMed CAS Google Scholar
• Chen G, Goeddel DV. TNF-R1 signaling: A beautiful pathway. Science 2002; 296(5573):1634–5.
  Article PubMed CAS Google Scholar
• Ting AT, Pimentel-Muinos FX, Seed B. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J 1996; 15(22):6189–96.
  PubMed CAS Google Scholar
• Kelliher MA, Grimm S, Ishida Y et al. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 1998; 8(3):297–303.
  Article PubMed CAS Google Scholar
• Yeh WC, Shahinian A, Speiser D et al. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 1997; 7(5):715–25.
  Article PubMed CAS Google Scholar
• Tada K Okazaki T, Sakon S et al. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death. J Biol Chem 2001; 276(39):36530–4.
  Article PubMed CAS Google Scholar
• Dunne A, O’Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: Signal transduction during inflammation and host defense. Sci STKE 2003; 2003(171):re3.
  Article PubMed Google Scholar
• Naito A, Azuma S, Tanaka S et al. Severe osteoptrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 1999; 4(6):353–62.
  Article PubMed CAS Google Scholar
• Lomaga MA, Yeh WC, Sarosi I et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 1999; 13(8):1015–24.
  PubMed CAS Google Scholar
• Kobayashi T, Walsh PT, Walsh MC et al. TRAF6 is a critical factor for dendritic cell maturation and development. Immunity 2003; 19(3):353–63.
  Article PubMed CAS Google Scholar
• Akiyama T, Maeda S, Yamane S et al. Dependence of self-tolerance on TRAF6-directed development of thymic stroma. Science 2005; 308(5719):248–51.
  Article PubMed CAS Google Scholar
• Deng L, Wang C, Spencer E et al. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000: 103(2):351–61.
  Article PubMed CAS Google Scholar
• Wang C, Deng L, Hong M et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412(6844):346–51.
  Article PubMed CAS Google Scholar
• Abbott DW, Wilkins A, Asara JM et al. The Crohn’s disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr Biol 2004; 14(24):2217–27.
  Article PubMed CAS Google Scholar
• Sun L, Deng L, Ea CK et al. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell 2004; 14(3):289–301.
  Article PubMed CAS Google Scholar
• Zhou H, Wertz I, O’Rourke K et al. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 2004; 427(6970):167–71.
  Article PubMed CAS Google Scholar
• Huang TT, Wuerzberger-Davis SM, Wu ZH et al. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 2003; 115(5):565–76.
  Article PubMed CAS Google Scholar
• Kovalenko A, Chable-Bessia C, Cantarella G et al. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 2003; 424(6950):801–5.
  Article PubMed CAS Google Scholar
• Brummelkamp TR, Nijman SM, Dirac AM et al. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 2003; 424(6950):797–801.
  Article PubMed CAS Google Scholar
• Tang ED, Wang CY, Xiong Y et al. A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J Biol Chem 2003; 278(39):37297–305.
  Article PubMed CAS Google Scholar
• Shi CS, Kehrl JH. Tumor necrosis factor (TNF)-induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (TRAF2). J Biol Chem 2003; 278(17):15429–34.
  Article PubMed CAS Google Scholar
• Habelhah H, Takahashi S, Cho SG et al. Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB. EMBO J 2004; 23(2):322–32.
  Article PubMed CAS Google Scholar
• Trompouki E, Hatzivassiliou E, Tsichritzis T et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 2003; 424(6950):793–6.
  Article PubMed CAS Google Scholar
• Kanayama A, Seth RB, Sun L et al. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol Cell 2004; 15(4):535–48.
  Article PubMed CAS Google Scholar
• Legler DF, Micheau O, Doucey MA et al. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 2003; 18(5):655–64.
  Article PubMed CAS Google Scholar
• Wertz IE, O’Rourke KM, Zhou H et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004; 430(7000):694–9.
  Article PubMed CAS Google Scholar
• Xia ZP, Chen ZJ. TRAF2: A double-edged sword? Sci STKE 2005; 2005(272): pe7.
  Google Scholar
• Grech AP, Amesbury M, Chan T et al. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. Immunity 2004; 21(5):629–42.
  Article PubMed CAS Google Scholar
• Hostager BS, Haxhinasto SA, Rowland SL et al. Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. J Biol Chem 2003; 278(46):45382–90.
  Article PubMed CAS Google Scholar
• Brown KD, Hostager BS, Bishop GA. Regulation of TRAF2 signaling by self-induced degradation. J Biol Chem 2002; 277(22):19433–8.
  Article PubMed CAS Google Scholar
• Li X, Yang Y, Ashwell JD. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 2002; 416(6878):345–7.
  Article PubMed Google Scholar
• Hsu H, Shu HB, Pan MG et al. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996; 84(2):299–308.
  Article PubMed CAS Google Scholar
• Cao Z, Xiong J, Takeuchi M et al. TRAF6 is a signal transducer for interleukin-1. Nature 1996; 383(6599):443–6.
  Article PubMed CAS Google Scholar
• Baud V, Liu ZG, Bennett B et al. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev 1999; 13(10):1297–308.
  PubMed CAS Google Scholar
• Kobayashi N, Kadono Y, Naito A et al. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J 2001; 20(6):1271–80.
  Article PubMed CAS Google Scholar
• Takatsuna H, Kato H, Gohda J et al. Identification of TIFA as an adapter protein that links tumor necrosis factor receptor-associated factor 6 (TRAF6) to interleukin-1 (IL-1) receptor-associated kinase-1 (IRAK-1) in IL-1 receptor signaling. J Biol Chem 2003; 278(14):12144–50.
  Article PubMed CAS Google Scholar
• Ea CK, Sun L, Inoue J et al. TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6. Proc Natl Acad Sci USA 2004; 101(43):15318–23.
  Article PubMed CAS Google Scholar
• Monks CR, Kupfer H, Tamir I et al. Selective modulation of protein kinase C-theta during T-cell activation. Nature 1997; 385(6611):83–6.
  Article PubMed CAS Google Scholar
• van Oers NS, Chen ZJ. Cell biology. Kinasing and clipping down the NF-kappa B trail. Science 2005; 308(5718):65–6.
  Article PubMed CAS Google Scholar
• Thome M, Tschopp J. TCR-induced NF-kappaB activation: A crucial role for Carmal, Bcl10 and MALT1. Trends Immunol 2003; 24(8):419–24.
  Article PubMed CAS Google Scholar
• Arenzana-Seisdedos F, Turpin P, Rodriguez M et al. Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci 1997; 110(Pt 3): 369–78.
  PubMed CAS Google Scholar
• Chiao PJ, Miyamoto S, Verma IM. Autoregulation of I kappa B alpha activity. Proc Natl Acad Sci USA 1994; 91(1):28–32.
  Article PubMed CAS Google Scholar
• Sun SC, Ganchi PA, Ballard DW et al. NF-kappa B controls expression of inhibitor I kappa B alpha: Evidence for an inducible autoregulatory pathway. Science 1993; 259(5103):1912–5.
  Article PubMed CAS Google Scholar
• Bignell GR, Warren W, Seal S et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 2000; 25(2):160–5.
  Article PubMed CAS Google Scholar
• Reiley W, Zhang M, Wu X et al. Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation. Mol Cell Biol 2005; 25(10)3886–95.
  Article PubMed CAS Google Scholar
• Reiley W, Zhang M, Sun SC. Negative regulation of JNK signaling by the tumor suppressor CYLD. J Biol Chem 2004; 279(53):55161–7.
  Article PubMed CAS Google Scholar
• Dixit VM, Green S, Sarma V et al. Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem 1990; 265(5):2973–8.
  PubMed CAS Google Scholar
• Opipari Jr AW, Hu HM, Yabkowitz R et al. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 1992; 267(18):12424–7.
  PubMed CAS Google Scholar
• Lee EG, Boone DL, Chai S et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 2000; 289(5488):2350–4.
  Article PubMed CAS Google Scholar
• Boone DL, Turer EE, Lee EG et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 2004; 5(10):1052–60.
  Article PubMed CAS Google Scholar
• Evans PC, Ovaa H, Hamon M et al. Zinc-finger protein A20 a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem J 2004; 378(Pt 3):727–34.
  Article PubMed CAS Google Scholar
• Yamaguchi K, Shirakabe K, Shibuya H et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 1995; 270(5244):2008–11.
  Article PubMed CAS Google Scholar
• Ninomiya-Tsuji J, Kishimoto K, Hiyama A et al. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 1999; 398(6724):252–6.
  Article PubMed CAS Google Scholar
• Ninomiya-Tsuji J, Kajino T, Ono K et al. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J Biol Chem 2003; 278(20):18485–90.
  Article PubMed CAS Google Scholar
• Takaesu G, Surabhi RM, Park KJ et al. TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. J Mol Biol 2003; 326(1):105–15.
  Article PubMed CAS Google Scholar
• Chen ZJ. Ubiquitin signaling in the NF-kappaB pathway. Nat Cell Biol 2005; 7(8):758–65.
  Article PubMed CAS Google Scholar
• Vidal S, Khush RS, Leulier F et al. Mutations in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel/NF-kappab-dependent innate immune responses. Genes Dev 2001; 15(15):1900–12.
  Article PubMed CAS Google Scholar
• Chen W, White MA, Cobb MH. Stimulus-specific requirements for MAP3 kinases in activating the JNK pathway. J Biol Chem 2002; 277(51):49105–10.
  Article PubMed CAS Google Scholar
• Silverman N, Zhou R, Erlich RL et al. Immune activation of NF-kappaB and JNK requires Drosophila TAK1. J Biol Chem 2003; 278(49):48928–34.
  Article PubMed CAS Google Scholar
• Shibuya H, Yamaguchi K, Shirakabe K et al. TAB1: An activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science 1996; 272(5265):1179–82.
  Article PubMed CAS Google Scholar
• Takaesu G, Kishida S, Hiyama A et al. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell 2000; 5(4):649–58.
  Article PubMed CAS Google Scholar
• Ishitani T, Takaesu G, Ninomiya-Tsuji J et al. Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. EMBO J 2003; 22(23):6277–88.
  Article PubMed CAS Google Scholar
• Cheung PC, Nebreda AR, Cohen P. TAB3, a new binding partner of the protein kinase TAK1. Biochem J 2004; 378(Pt 1):27–34.
  Article PubMed CAS Google Scholar
• a.Zhou R, Silverman N, Hong M et al. The role of ubiquitnation in Drosophila innate immunity. J Biol Chem 2005; Epub ahead of print].
  Google Scholar
• Sanjo H, Takeda K, Tsujimura T et al. TAB2 is essential for prevention of apoptosis in fetal liver but not for interleukin-1 signaling. Mol Cell Biol 2003; 23(4):1231–8.
  Article PubMed CAS Google Scholar
• Cha GH, Cho KS, Lee JH et al. Discrete functions of TRAF1 and TRAF2 in Drosophila melanogaster mediated by c-Jun N-terminal kinase and NF-kappaB-dependent signaling pathways. Mol Cell Biol 2003; 23(22):7982–91.
  Article PubMed CAS Google Scholar
• Kishimoto K, Matsumoto K, Ninomiya-Tsuji J. TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop. J Biol Chem 2000; 275(10):7359–64.
  Article PubMed CAS Google Scholar
• Sakurai H, Miyoshi H, Mizukami J et al. Phosphorylation-dependent activation of TAK1 mitogen-activated protein kinase kinase kinase by TAB1. FEBS Lett 2000; 474(2–3):141–5.
  Article PubMed CAS Google Scholar
• Komatsu Y, Shibuya H, Takeda N et al. Targeted disruption of the Tab1 gene causes embryonic lethality and defects in cardiovascular and lung morphogenesis. Mech Dev 2002; 119(2):239–49.
  Article PubMed CAS Google Scholar
• Huang Q, Yang J, Lin Y et al. Differential regulation of interleukin 1 receptor and Toll-like receptors signaling by MEKK3. Nat Immunol 2004; 5(1):98–103.
  Article PubMed CAS Google Scholar
• Yang J, Lin Y, Guo Z et al. The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol 2001; 2(7):620–4.
  Article PubMed CAS Google Scholar
• Xu LG, Li LY, Shu HB. TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis. J Biol Chem 2004; 279(17):17278–82.
  Article PubMed CAS Google Scholar
• Tobiume K, Matsuzawa A, Takahashi T et al. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2001; 2(3):222–8.
  Article PubMed CAS Google Scholar
• Nishitoh H, Saitoh M, Mochida Y et al. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol Cell 1998; 2(3):389–95.
  Article PubMed CAS Google Scholar
• Matsuzawa A, Saegusa K, Noguchi T et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 2005; 6(6):587–92.
  Article PubMed CAS Google Scholar
• Kawai T, Sato S, Ishii KJ et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004; 5(10):1061–8.
  Article PubMed CAS Google Scholar
• Honda K, Yanai H, Mizutani T et al. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci USA 2004; 101(43):15416–21.
  Article PubMed CAS Google Scholar
• Uematsu S, Sato S, Yamamoto M et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7-and TLR9-mediated interferon-{alpha} induction. J Exp Med 2005; 201(6):915–23.
  Article PubMed CAS Google Scholar